Design Therapeutics Inc (DSGN)
EBITDA Growth
-16.35%
Quarterly · Period ending:
DSGN EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-16.35%period ending
Latest reported-16.35%period ending
DSGN Quarterly EBITDA YoY % (-811.08% → -16.35%)
Year-over-year change
High-resolution chart · PNG
DSGN ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| -16.3488% | |
| 0.4386% | |
| -17.3234% | |
| -30.7% | |
| -62.6095% | |
| -60.1533% | |
| -15.3623% | |
| 17.6719% | |
| 41.2139% | |
| 42.802% | |
| 32.0167% | |
| 11.048% | |
| -32.8503% | |
| -45.3766% | |
| -56.7513% | |
| -55.8962% | |
| -95.5273% | |
| -132.2586% | |
| -184.755% | |
| -373.8455% | |
| -421.121% | |
| -811.0754% |